Multiple Sclerosis-like Features in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Red Flag, Red Herring, or Regular Occurrence?
Background: MOG antibody-associated disease (MOGAD) is an inflammatory demyelinating disorder characterized by IgG antibodies against...
Delayed Visual Improvement in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis
Background: Bilateral involvement and severe visual impairment can occur in the acute phase of pediatric myelin oligodendrocyte...
Treatment Resistant Tinea Corporis in Multiple Sclerosis Patients Treated with Ocrelizumab
Background: Tinea corporis is a fungal infection of the skin excluding the face, hands, feet, scalp, nail, or groin. It mostly affects the...
Multiple Sclerosis in a Patient with Neurofibromatosis Type-1
Background: The association of multiple sclerosis (MS) and neurofibromatosis type 1 (NF1) has been rarely reported. Objectives: To report a...
Non-Intensive Exercise to Prepare for Intensive, Task-Oriented Rehabilitation in People with Progressive Multiple Sclerosis: A Two-Participant Case Study
Background: There is a need for exercise strategies that maximize motor function and related changes in the central nervous system for...
Immunotherapy-Responsive Post COVID-19 Central Nervous System Inflammatory Syndrome, a Case Report
Background: COVID 19 virus can infect the central and peripheral nervous system with or without other systemic manifestations of infection....
Positive Outcome with Alemtuzumab in Hispanic Puerto Rican Woman with Highly Active Multiple Sclerosis after Various Failed Disease Modifying Therapies
Background: Multiple sclerosis (MS) is the most common autoimmune demyelinating disease of the central nervous system (CNS). It is an...
Case Report: Lama-2 Related Muscular Dystrophy Mimicking Multiple Sclerosis
Background: There is increased prevalence of genetic testing within the field of neurology and provider awareness of genetic conditions...
Long Arm Serial Casting Results in Decreased Spasticity and Improved Function for Woman with MS
Background: Spasticity is present among 60-80% of individuals with Multiple Sclerosis (Etoom et al, 2018). One-third of people with...